Whole-Exome Sequencing of 2,000 Danish Individuals and the Role of Rare Coding Variants in Type 2 Diabetes Research, Nora
Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. Research, Nora
Trends and clinico-epidemiological features of human rabies cases in Bangladesh 2006-2018 Research, Nora
Trends in overweight and obesity in Danish children and adolescents: 2000-2008 – exploring changes according to parental education Research, Nora
Impacts of NMVOC emissions on human health in European countries for 2000-2010: Use of sector-specific substance profiles Research, Nora
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion Part III on the substantiation of health claims related to various food(s)/food constituent(s) not supported by pertinent human data (ID 644, 946, 1717, 1730, 1742, 1760, 1871, 1894, 1910, 1926, 1933, 2000, 2024, 2028, 2095, 2124, 2127, 2137, 2213, 2332, 2337, 2380, 2435, 2833, 2917, 3072, 3075, 3080, 3129, 3193, 3636, 4037, 4044, 4313) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 Research, Nora
Scientific Opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006 Research, Nora
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the modification of the authorisation of a health claim related to plant sterol esters and lowering blood LDL-cholesterol; high blood LDL-cholesterol is a risk factor in the development of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006, following a request in accordance with Article 19 of Regulation (EC) No 1924/2006 Research, Nora